dc.creatorGonzález Jamett, Arlek M.
dc.creatorHaro-Acuña, Valentina
dc.creatorMomboisse, Fanny
dc.creatorCaviedes, Pablo
dc.creatorBevilacqua, Jorge
dc.creatorCárdenas, Ana María
dc.date.accessioned2019-03-15T16:05:52Z
dc.date.available2019-03-15T16:05:52Z
dc.date.created2019-03-15T16:05:52Z
dc.date.issued2014
dc.identifierJournal of Neurochemistry, Volumen 128, Issue 2, 2018, Pages 210-223
dc.identifier00223042
dc.identifier14714159
dc.identifier10.1111/jnc.12455
dc.identifierhttps://repositorio.uchile.cl/handle/2250/166067
dc.description.abstractDynamin-2 is a pleiotropic GTPase whose best-known function is related to membrane scission during vesicle budding from the plasma or Golgi membranes. In the nervous system, dynamin-2 participates in synaptic vesicle recycling, post-synaptic receptor internalization, neurosecretion, and neuronal process extension. Some of these functions are shared with the other two dynamin isoforms. However, the involvement of dynamin-2 in neurological illnesses points to a critical function of this isoform in the nervous system. In this regard, mutations in the dynamin-2 gene results in two congenital neuromuscular disorders. One of them, Charcot-Marie-Tooth disease, affects myelination and peripheral nerve conduction, whereas the other, Centronuclear Myopathy, is characterized by a progressive and generalized atrophy of skeletal muscles, yet it is also associated with abnormalities in the nervous system. Furthermore, single nucleotide polymorphisms located in the dynamin-2 gene have been associated
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceJournal of Neurochemistry
dc.subjectAlzheimer's disease
dc.subjectcentronuclear myopathy
dc.subjectCharcot-Marie-Tooth neuropathy
dc.subjectcytoskeleton
dc.subjectdynamin-2
dc.subjectvesicles trafficking
dc.titleDynamin-2 in nervous system disorders
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución